Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01167712 · BASELINE

Baseline characteristics

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · Source last updated 2026-05-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      346
    2. group Id
      BG001
      value
      346
    3. group Id
      BG002
      value
      692
    units
    Participants
groups
  1. description
    Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. Bevacizumab: Given IV Carboplatin: Given IV Computed Tomography: Correlative studies Paclitaxel: Given IV Therapeutic Conventional Surgery: Undergo surgery
    id
    BG000
    title
    Arm I (Adjuvant Chemotherapy Suboptimally Debulked)
  2. description
    Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. Patients undergo interval cytoreductive surgery between courses 3 and 4. Bevacizumab: Given IV Carboplatin: Given IV Computed Tomography: Correlative studies Paclitaxel: Given IV Therapeutic Conventional Surgery: Undergo surgery
    id
    BG001
    title
    Arm II (Neoadjuvant Chemotherapy)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          214
        2. group Id
          BG001
          value
          217
        3. group Id
          BG002
          value
          431
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          132
        2. group Id
          BG001
          value
          129
        3. group Id
          BG002
          value
          261
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          346
        2. group Id
          BG001
          value
          346
        3. group Id
          BG002
          value
          692
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. calculate Pct
    false
    classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      Canada
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          345
        2. group Id
          BG001
          value
          345
        3. group Id
          BG002
          value
          690
      title
      United States
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
      title
      South Korea
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Region of Enrollment
    unit Of Measure
    Participants
population Description
Newly diagnosed women with high-risk early stage or advanced stage epithelial ovarian cancer.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      346
    2. group Id
      BG001
      value
      346
    3. group Id
      BG002
      value
      692
    units
    Participants
groups
  1. description
    Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. Bevacizumab: Given IV Carboplatin: Given IV Computed Tomography: Correlative studies Paclitaxel: Given IV Therapeutic Conventional Surgery: Undergo surgery
    id
    BG000
    title
    Arm I (Adjuvant Chemotherapy Suboptimally Debulked)
  2. description
    Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. Patients undergo interval cytoreductive surgery between courses 3 and 4. Bevacizumab: Given IV Carboplatin: Given IV Computed Tomography: Correlative studies Paclitaxel: Given IV Therapeutic Conventional Surgery: Undergo surgery
    id
    BG001
    title
    Arm II (Neoadjuvant Chemotherapy)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          214
        2. group Id
          BG001
          value
          217
        3. group Id
          BG002
          value
          431
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          132
        2. group Id
          BG001
          value
          129
        3. group Id
          BG002
          value
          261
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          346
        2. group Id
          BG001
          value
          346
        3. group Id
          BG002
          value
          692
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. calculate Pct
    false
    classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
      title
      Canada
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          345
        2. group Id
          BG001
          value
          345
        3. group Id
          BG002
          value
          690
      title
      United States
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
      title
      South Korea
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Region of Enrollment
    unit Of Measure
    Participants
population Description
Newly diagnosed women with high-risk early stage or advanced stage epithelial ovarian cancer.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice